Bank Of New York Mellon Corp Alkermes Plc. Call Options Transaction History
Bank Of New York Mellon Corp
- $521 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
358Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$683 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$472 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$348 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$211 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$195 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $3.84B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...